Allelic polymorphisms of thymidylate synthase gene and their haplotypes as predictors of the therapeutic response to methotrexate in patients with rheumatoid arthritis

Methotrexate (MT) is recognized as the main component of the treat to target strategy in patients with rheumatoid arthritis (RA). Unfortunately, MT therapy is not equally effective in all patients with RA, some of them are resistant to such treatment, and have steady progression of destructive chang...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: I. V. Devald, E. A. Khodus, E. B. Khromova, O. B. Nesmeyanova, A. L. Burmistrova
Aineistotyyppi: Artikkeli
Kieli:Russian
Julkaistu: IMA PRESS LLC 2019-05-01
Sarja:Научно-практическая ревматология
Aiheet:
Linkit:https://rsp.mediar-press.net/rsp/article/view/2697